default author photo

Christian J. Cea-Curry

Harvard University - Department of Medical Oncology

450 Brookline Avenue

Boston, MA 02115

United States

SCHOLARLY PAPERS

2

DOWNLOADS

252

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study

Number of pages: 72 Posted: 03 Mar 2022
Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Inc., The Binding Site Inc., Cornell University - Weill Cornell Medicine, Harvard University - Department of Medical Oncology, Mayo Clinic - Alix School of Medicine, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Medical Oncology, Mayo Clinic, City of Hope - City of Hope Cancer Center, Johns Hopkins University - Johns Hopkins Hospital, Mayo Clinic, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 157 (474,889)
Citation 3

Abstract:

Loading...

Multiple myeloma, monoclonal gammopathy, cancer screening, mass spectrometry

2.

Prevalence of Monoclonal Gammopathies Including an Age-Related Monoclonal Gammopathy of Indeterminate Potential (MGIP) in a Racially Diverse US Population Screened by Mass Spectrometry

Number of pages: 28 Posted: 06 Dec 2021
Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Inc., The Binding Site Inc., Harvard University - Department of Medical Oncology, Mayo Clinic - Alix School of Medicine, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Medical Oncology, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 95 (720,278)

Abstract:

Loading...

Monoclonal gammopathy, Cancer screening, Early detection, Racial disparities, Mass spectrometry